ROYAL BANK OF CANADA - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 164 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2024$68,000
-79.3%
4,304
-78.9%
0.00%
Q4 2023$329,000
+122.3%
20,419
+74.6%
0.00%
Q3 2023$148,000
+29.8%
11,697
+44.5%
0.00%
Q2 2023$114,000
+17.5%
8,095
+29.1%
0.00%
Q1 2023$97,000
-34.0%
6,271
-30.3%
0.00%
Q4 2022$147,000
+1370.0%
8,998
+1492.6%
0.00%
Q3 2022$10,000
+233.3%
565
+123.3%
0.00%
Q2 2022$3,000
-87.0%
253
-89.6%
0.00%
Q1 2022$23,000
-72.3%
2,443
-71.3%
0.00%
Q4 2021$83,000
+361.1%
8,523
+1542.2%
0.00%
Q3 2021$18,000
+800.0%
519
+1053.3%
0.00%
Q2 2021$2,000
-97.9%
45
-97.9%
0.00%
Q1 2021$97,000
+9600.0%
2,164
+8556.0%
0.00%
Q4 2020$1,000
-50.0%
25
-28.6%
0.00%
Q2 2020$2,000
-95.1%
35
-96.5%
0.00%
Q1 2020$41,000
-66.1%
1,010
-48.2%
0.00%
Q4 2019$121,000
+1412.5%
1,948
+471.3%
0.00%
Q2 2019$8,000
-20.0%
341
+28.2%
0.00%
Q3 2018$10,000
+400.0%
266
+358.6%
0.00%
Q2 2018$2,0000.0%58
-28.4%
0.00%
Q4 2017$2,000810.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$19,824,86914.35%
Redmile Group, LLC 3,593,317$58,894,4662.41%
BRAIDWELL LP 3,271,513$53,620,0981.80%
Parkman Healthcare Partners LLC 344,920$5,653,2391.50%
ARMISTICE CAPITAL, LLC 5,172,000$84,769,0801.48%
Ikarian Capital, LLC 367,119$6,017,0811.45%
Sunesis Advisors, LLC 96,299$1,578,3411.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,228$38,503,8470.80%
Hillsdale Investment Management Inc. 328,200$5,379,1980.46%
Avidity Partners Management LP 1,126,000$18,455,1400.40%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders